Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 3 | 3116 | 226 | 0.7812 | 0.7324 | 0.0725 | 0.0776 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 1 | 2852 | 143 | 0.7815 | 0.9528 | 0.0501 | 0.0436 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 2580 | 113 | 0.7822 | 0.8880 | 0.0438 | 0.0519 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 2523 | 106 | 0.7883 | 0.7091 | 0.0420 | 0.0504 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.316 | 0.000 | uM | 72 | hr | 2 | 2781 | 210 | 0.7888 | 0.7819 | 0.0755 | 0.0740 |
WM-115 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 3266 | 231 | 0.7892 | 0.7584 | 0.0707 | 0.0699 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 854 | 49 | 0.7905 | 0.7915 | 0.0574 | 0.0491 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3246 | 205 | 0.7908 | 0.7665 | 0.0632 | 0.0659 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 1078 | 44 | 0.7919 | 0.7554 | 0.0408 | 0.0454 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 1024 | 31 | 0.7923 | 0.6896 | 0.0303 | 0.0319 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 1 | 5588 | 784 | 0.7966 | 0.8682 | 0.1403 | 0.1425 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 1 | 15518 | 861 | 0.7973 | 0.8926 | 0.0555 | 0.0523 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16059 | 813 | 0.7981 | 0.7489 | 0.0506 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 1047 | 45 | 0.7995 | 0.7976 | 0.0430 | 0.0486 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.316 | 0.000 | uM | 72 | hr | 3 | 2794 | 188 | 0.7996 | 0.7819 | 0.0673 | 0.0740 |
WM-115 | Vemurafenib | I-BET | 0.316 | 0.000 | uM | 72 | hr | 3 | 2983 | 183 | 0.8032 | 0.7817 | 0.0613 | 0.0634 |
WM-115 | Vemurafenib | I-BET | 0.000 | 1.000 | uM | 72 | hr | 2 | 2961 | 158 | 0.8041 | 0.8332 | 0.0534 | 0.0539 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 3316 | 223 | 0.8043 | 0.7665 | 0.0672 | 0.0659 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 2697 | 158 | 0.8050 | 0.7710 | 0.0586 | 0.0544 |
WM-115 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 3619 | 242 | 0.8072 | 0.8216 | 0.0669 | 0.0659 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 1106 | 50 | 0.8088 | 0.7554 | 0.0452 | 0.0454 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 1049 | 35 | 0.8090 | 0.9306 | 0.0334 | 0.0304 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 3472 | 249 | 0.8152 | 0.8594 | 0.0717 | 0.0671 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 2625 | 125 | 0.8154 | 0.7361 | 0.0476 | 0.0573 |
WM-115 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 3649 | 235 | 0.8160 | 0.8216 | 0.0644 | 0.0659 |